nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An overview of the central control of weight regulation and the effect of antipsychotic medication
|
Tighe, Sheila |
|
2005 |
|
6_suppl |
p. 36-46 |
artikel |
2 |
Challenges in advancing mental and physical health of patients with serious mental illness
|
Dursun, Serdar |
|
2005 |
|
6_suppl |
p. 3-5 |
artikel |
3 |
Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?
|
Gough, Stephen C. L. |
|
2005 |
|
6_suppl |
p. 47-55 |
artikel |
4 |
Diabetes and schizophrenia 2005: are we any closer to understanding the link?
|
Holt, Richard I. G. |
|
2005 |
|
6_suppl |
p. 56-65 |
artikel |
5 |
Do guidelines for severe mental illness promote physical health and well-being?
|
Citrome, Leslie |
|
2005 |
|
6_suppl |
p. 102-109 |
artikel |
6 |
Improving patient outcomes in schizophrenia: achieving remission
|
Nasrallah, Henry A. |
|
2006 |
|
6_suppl |
p. 57-61 |
artikel |
7 |
Lipids for Psychiatrists - an overview
|
Young, Ian S. |
|
2005 |
|
6_suppl |
p. 66-75 |
artikel |
8 |
Metabolic and lifestyle issues and severe mental illness - new connections to well-being?
|
|
|
2005 |
|
6_suppl |
p. 118-122 |
artikel |
9 |
Metabolic Syndrome and Cardiovascular Disease
|
Citrome, Leslie |
|
2005 |
|
6_suppl |
p. 84-93 |
artikel |
10 |
Metabolism, lifestyle and bipolar affective disorder
|
Morriss, Richard |
|
2005 |
|
6_suppl |
p. 94-101 |
artikel |
11 |
Obesity - an epidemic of the twenty-first century: an update for psychiatrists
|
Holt, Richard I. G. |
|
2005 |
|
6_suppl |
p. 6-15 |
artikel |
12 |
Raising the bar for treatment expectations in schizophrenia: achieving remission as a routine goal of antipsychotic pharmacotherapy
|
Nasrallah, Henry A. |
|
2006 |
|
6_suppl |
p. 3-5 |
artikel |
13 |
Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses
|
Turner, Martin S |
|
2006 |
|
6_suppl |
p. 20-37 |
artikel |
14 |
Symptom domains of schizophrenia: the role of atypical antipsychotic agents
|
Burton, Simon |
|
2006 |
|
6_suppl |
p. 6-19 |
artikel |
15 |
The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link?
|
Bushe, Chris |
|
2005 |
|
6_suppl |
p. 76-83 |
artikel |
16 |
The relationship between patient satisfaction and treatment outcomes in schizophrenia
|
Chue, Pierre |
|
2006 |
|
6_suppl |
p. 38-56 |
artikel |
17 |
The role of lifestyle interventions and weight management in schizophrenia
|
Bushe, Chris |
|
2005 |
|
6_suppl |
p. 28-35 |
artikel |
18 |
Weight change with atypical antipsychotics in the treatment of schizophrenia
|
Haddad, Peter |
|
2005 |
|
6_suppl |
p. 16-27 |
artikel |
19 |
Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic
|
Ascher-Svanum, Haya |
|
2005 |
|
6_suppl |
p. 110-117 |
artikel |